AzTrials
AzTrials

DementiaNCT06817876

Connecting Caregivers With Community Services: The Care Buddy Platform

A study testing Care Buddy in people with Dementia, run by Duke-NUS Graduate Medical School at 1 site in Singapore.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to develop a mobile-app (Care Buddy) which will be a one-stop integrated source of information and technology-based solutions for caregivers of people with dementia (PWDs). Read more about this study

Who is it for?
Ages 21 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Dementia
What is being tested?
Care Buddy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
1 siteSingapore
Study dates
1 Apr 2025to 31 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • The inclusion criteria for patients are
  • Singaporean/Permanent residents
  • Age 21 years of age or older
  • Main person or one of the main persons involved in making decisions regarding treatment patient receives or responsible for ensuring the well-being of the patient
  • An active primary caregiver for at least 6 months, and planning to remain the primary caregiver for the next 2 years
  • Is a family member of the patient with dementia
Show all 11Show fewer
  • Can read and write in English
  • Accessible by telephone to schedule interviews
  • Has familiarity with use of technology (e.g., computers, tablets, or internet) and is able to complete surveys, forms using digital technology
  • Intact cognition determined through the Abbreviated Mental Test (AMT) for those who are ≥ 65 years old.
  • Caregivers who score >=9 on the 6-item Zarit Burden scale

Who cannot join

  • Caregivers of patients staying in nursing home or other long-term care facility with no intention of being discharged will not be eligible however, if the patient is admitted to respite care for short/long term duration after being recruited, caregivers can continue to participate.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Chetna Malhotra, MD, MPH contact

+65 65165692

chetna.malhotra@duke-nus.edu.sg

Singapore1 site, 1 recruiting

  • Duke-NUS

    Singapore, Singapore

    Shimoni Shah, MPH, 65 65161769 ext. 61769, shimoni@nus.edu.sg

    Chetna Malhotra, MD, MPH

    Recruiting

Other trials in Singapore

About this study

The study aims to develop a mobile-app (Care Buddy) which will be a one-stop integrated source of information and technology-based solutions for caregivers of people with dementia (PWDs). Study aims to bring caregivers into closer partnerships with the wider ecosystem (e.g., healthcare practitioners, community services, peer support, and care service providers) which will ultimately improve outcomes for both PWDs and their caregivers.

Read the detailed description

This is a 5-year study with various stages: 1) proof-of-concept stage to design and develop the Care buddy intervention, 2) proof-of-value stage to assess the feasibility, acceptability and satisfaction with the Care buddy intervention among informal caregivers of PWDs, 3) test-bedding stage to assess the efficacy and cost-effectiveness of the Care buddy intervention versus usual care among informal caregivers of PWDs with help of a multi-centre 2-arm RCT and 4) deployment stage to scale up the intervention at multiple centres across Singapore, monitor its adoption and outcomes and assess any organizational and individual barriers to adoption.

By the end of the proposed five-year project, investigators aim to develop and evaluate the technology as well as achieve widespread adoption among caregivers of PWDs. Investigators want to enable easy access to information, provide decisional and social support, improve the reach and uptake of existing community service providers, and assist with coordination among multiple informal and professional caregivers through the journey of dementia caregiving and into the bereavement phase.

Conditions
Dementia
Being tested
Care Buddy
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Care BuddyDevice

    Care Buddy mobile intervention will be a one-stop solution for caregivers of dementia patients and help them in their care-giving journey by providing them solutions to manage behavioural problems, physical conditions of their loved one. The app will be multi-component and will provide tools for the caregiver to manage their stress and burden. It will provide information on dementia, list of service providers, information on grief, financial support. This app will provide a platform for all enrolled caregivers to chat with each other and provide social support.

Study groups in NCT06817876
Study groupRoleWhat they receive
CareBuddyExperimentalCaregivers of person with dementia who will be randomized in this arm will have access to the CareBuddy mobile app on their phone. They will be using this app for 1 year and will be followed up every 2 months.
Receives: Device: Care Buddy
Usual careNo interventionCaregivers of person with dementia who will be randomized in this arm will continue usual care for their loved one. They will be enrolled for 1 year and will be followed up every 2 months.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver Psychological well-being

    Flourish - range - 8 - 56, high score represents a person with many psychological resources and strengths

    Measured: 1 year from data collection

  2. Caregiver social scale

    Friendship scale - The score range is 0-24. A high score represents social connectedness and a score of "0" complete social isolation

    Measured: 1 year from data collection

  3. Caregiver Dementia Knowledge

    The Dementia Knowledge Assessment Tool - range - 0-21. High score equals to higher knowledge of dementia.

    Measured: 1 year from data collection

  4. Caregiver Impact

    Revised Memory \& Behavior Problem checklist - range - 0-96 Higher score indicates increased impact.

    Measured: 1 year from data collection

  5. Caregiver Burden

    Zarit Burden scale - range 0-88. 0 - 21 little or no burden, 21 - 40 mild to moderate burden, 41 - 60 moderate to severe burden, 61 - 88 severe burden >34 - clinically significant burden.

    Measured: 1 year from data collection

  6. Caregiver Stress

    Perceived Stress Scale: Scoring: PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items.

    Measured: 1 year from data collection

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2025
  2. Study start1 Apr 2025
  3. Primary completion31 May 2026 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06817876
Sponsor's protocol ID
2022-309
Status last verified
Oct 2025
First submitted
5 Feb 2025
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Care Buddy in people with Dementia, run by Duke-NUS Graduate Medical School at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chetna Malhotra, MD, MPH (+65 65165692, chetna.malhotra@duke-nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver Psychological well-being (time frame: 1 year from data collection). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06817876.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in